Neogen Co. (NASDAQ:NEOG – Get Free Report) COO Douglas Edward Jones acquired 10,000 shares of Neogen stock in a transaction dated Wednesday, April 17th. The stock was purchased at an average price of $12.36 per share, with a total value of $123,600.00. Following the completion of the purchase, the chief operating officer now owns 46,131 shares of the company’s stock, valued at $570,179.16. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.
Neogen Stock Performance
Shares of NASDAQ:NEOG opened at $12.14 on Thursday. The business’s 50 day moving average price is $15.61 and its 200-day moving average price is $16.58. The firm has a market capitalization of $2.63 billion, a PE ratio of 1,215.22 and a beta of 1.13. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.82 and a quick ratio of 2.66. Neogen Co. has a 1 year low of $11.74 and a 1 year high of $24.09.
Neogen (NASDAQ:NEOG – Get Free Report) last released its quarterly earnings data on Tuesday, April 9th. The company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.02). The company had revenue of $228.80 million for the quarter, compared to analyst estimates of $230.01 million. Neogen had a return on equity of 3.35% and a net margin of 0.17%. The business’s quarterly revenue was up 4.8% on a year-over-year basis. During the same period last year, the firm posted $0.12 EPS. As a group, equities research analysts expect that Neogen Co. will post 0.5 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Neogen
Wall Street Analysts Forecast Growth
Separately, Piper Sandler reduced their price target on Neogen from $19.00 to $17.00 and set a “neutral” rating for the company in a research report on Monday.
Read Our Latest Stock Report on NEOG
About Neogen
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
Featured Articles
- Five stocks we like better than Neogen
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- United Airlines Soars on Earnings Beat
- How to Choose Top Rated Stocks
- J.B. Hunt Hits the Skids: Lower Prices to Come
- CD Calculator: Certificate of Deposit Calculator
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.